Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

BACKGROUND: Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. METHODS AND FINDINGS: We reviewed 227 AoV Ca patients with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Ha, Hye rim, Oh, Do-Youn, Kim, Tae-Yong, Lee, KyoungBun, Kim, Kyubo, Lee, Kyung-Hun, Han, Sae-Won, Chie, Eui Kyu, Jang, Jin-Young, Im, Seock-Ah, Kim, Tae-You, Kim, Sun-Whe, Bang, Yung-Jue
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4790941/
https://ncbi.nlm.nih.gov/pubmed/26974670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151406
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia